Poolbeg Pharma engages in the research and development of novel treatments for infectious diseases.
Poolbeg Pharma has raised $5.6M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2025.
Poolbeg Pharma's investors include RS Participaties, Disruptive Technologies Innovation Fund, Cathal Friel.
Poolbeg Pharma is headquartered in Dublin, Ireland.
Poolbeg Pharma engages in the research and development of novel treatments for infectious diseases.
Poolbeg Pharma is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Poolbeg Pharma — Funding & Investors." VCBacked, June 2, 2025, https://www.vcbacked.co/company/poolbeg-pharma. Accessed August 13, 2026.
VCBacked. (2025). Poolbeg Pharma — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/poolbeg-pharma
{{cite web |title=Poolbeg Pharma — Funding & Investors |url=https://www.vcbacked.co/company/poolbeg-pharma |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated